Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Scienture Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 537.5K | 586.9K | +49.4K (+9.2%) |
| Value | $1.49M | $953.0K | −$536.0K (−36.0%) |
New holders (3)
Institutions that held Scienture Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealth Dimensions Group, Ltd. | 30,979 | $50.0K | 0.02% |
| Ronald Blue Trust, Inc. | 5,354 | $15.0K | 0.00% |
| Royal Bank of Canada | 1,000 | $2.00K | 0.00% |
Sold out (3)
Institutions that held Scienture Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 11,624 | $32.0K |
| BlackRock Inc. | 10,319 | $28.0K |
| Citigroup Inc | 300 | $1.00K |